World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
91
Citations
29569
World Ranking
1039
National Ranking
91

Medicine

D-Index
91
Citations
29675
World Ranking
11777
National Ranking
1119

Fionula M. Brennan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Fionula M. Brennan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 216 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Fionula M. Brennan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Fionula M. Brennan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 91 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Fionula M. Brennan was affiliated with the University of Oxford in the United Kingdom. Their research primarily focused on the field of Medicine, with an emphasis on Rheumatology and Oncology as key subfields.

Their scholarly contributions included work on topics such as:

  • Rheumatoid Arthritis Research and Therapies
  • Cytokine Signaling Pathways and Interactions
  • Systemic Lupus Erythematosus Research

Brennan's publication record includes papers published in the venues Scientific Reports and Value in Health. Some notable papers included:

  • Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course, 2020, Scientific Reports
  • RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022, 2024, Value in Health

Frequent co-authors of Brennan's work included:

  • Attila A. Seyhan
  • Bernard Gregory
  • Adam P. Cribbs
  • Sundeept Bhalara
  • Yizheng Li

The research topics and collaborations suggested a focus on inflammatory and autoimmune diseases, with an emphasis on understanding molecular pathways involved in such conditions.

Best Publications

  • ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

    Marc Feldmann;Fionula M. Brennan;Ravinder N. Maini

  • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Evidence that cytokines play a role in rheumatoid arthritis

    Fionula M. Brennan;Iain B. McInnes

  • Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

    F M Brennan;D Chantry;A Jackson;R Maini

  • Rheumatoid Arthritis

    Unknown

  • Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

    Kim Midwood;Sandra Sacre;Anna M Piccinini;Julia Inglis

  • Immunoregulatory role of interleukin 10 in rheumatoid arthritis.

    Peter D. Katsikis;Cong Qiu Chu;Fionula M. Brennan;Ravinder N. Maini

  • TNF alpha--a pivotal role in rheumatoid arthritis?

    F M Brennan;R N Maini;M Feldmann

  • Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.

    Andrew D. Foey;Sarah L. Parry;Lynn M. Williams;Marc Feldmann

  • Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.

    A P Cope;D Aderka;M Doherty;H Engelmann

  • Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.

    Catherine Haworth;Fionula M. Brennan;David Chantry;Martin Turner

  • Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent.

    B Foxwell;K Browne;J Bondeson;C Clarke

  • Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.

    Satomichi Yoshimura;Jan Bondeson;Brian M. J. Foxwell;Fionula M. Brennan

  • Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

    A. P. Cope;M. Londei;N. R. Chu;S. B. A. Cohen

  • Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

    Fionula M. Brennan;Claus O. C. Zachariae;David Chantry;Christian G. Larsen

  • Cytokines in autoimmunity.

    Fionula M. Brennan;Marc Feldmann

  • Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.

    Bent W. Deleuran;Cong‐Qiu ‐Q Chu;Max Field;Fionula M. Brennan

  • Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

    Jan Bondeson;Brian Foxwell;Fionula Brennan;Marc Feldmann

  • Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

    David A. Joyce;Deena P. Gibbons;Patricia Green;James H. Steer

  • Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

    Marco Londei;Corinne M. Savill;Adrienne Verhoef;Fionula Brennan

  • Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

    Ravinder N. Maini;Michael J. Elliott;Fionula M. Brennan;Richard O. Williams

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Brian M. J. Foxwell
Brian M. J. Foxwell Imperial College London
Ravinder N. Maini
Ravinder N. Maini Imperial College London
Andrew P. Cope
Andrew P. Cope King's College London
Richard O. Williams
Richard O. Williams University of Oxford
Martin R. Turner
Martin R. Turner University of Oxford
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Peter C. Taylor
Peter C. Taylor University of Oxford
Peter D. Katsikis
Peter D. Katsikis Erasmus University Rotterdam
Evangelos Andreakos
Evangelos Andreakos Academy of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees can open doors to specialized healthcare roles. Many professionals explore acute care nurse practitioner programs to transition into roles that focus on complex patient care, which often overlaps with immunological conditions.

Accelerated study options are becoming increasingly popular for faster entry into the field. For example, accelerated NP programs allow registered nurses and non-nurses alike to quickly advance their qualifications, facilitating a quicker path to immunology-related specialties.

Non-nurses looking to enter the healthcare field can also benefit from targeted programs such as online RN programs for non nurses in Florida. These programs provide a foundation in clinical skills, enabling a future focus on immunological care and research.

For those seeking a more foundational nursing education before specializing, accelerated nursing programs offer a streamlined route to obtaining a Bachelor of Science in Nursing (BSN), which can serve as a critical step toward a career in immunology and related healthcare fields.

Best Scientists Citing Fionula M. Brennan

Recently Published Articles